WEST LAFAYETTE, Ind., March 31, 2011 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted therapies for the treatment of cancer and inflammatory diseases, announced today that Ron Ellis, president and CEO of Endocyte, will present at the upcoming Leerink Swann Cancer Roundtable Conference on Thursday, April 7th, 2011, at 11:20 a.m. EDT. Mr. Ellis also will be participating on a panel entitled, "First in Class Agents on the Horizon and Novel Platforms for Cancer," at 9:45 a.m. EDT. The conference is being held at the Roosevelt Hotel in New York City.
